Abstract

Summary

Melanopsin-containing retinal ganglion cells (ipRGCs), which drive circadian photoentrainment and the pupillary light reflex, are fully resistant to NMDA-induced excitotoxicity that destroys the majority of conventional RGCs. This resilience suggests that circadian light-sensing capacity may be preserved even in retinal conditions involving excitotoxic damage, with implications for lighting strategies in patients with certain retinal pathologies.
Abstract

Key Findings

  • NMDA intravitreal injection caused loss of 72% of conventional Brn3a+ RGCs within 7 days (reduced to 28% of baseline), with numbers stabilizing at 19% of baseline by 15 months.
  • Melanopsin+ RGC counts showed a transient, significant decrease at 3 days post-injection but fully recovered to normal levels by 7 days, with no cell death detected.
  • Control retinas contained mean totals of 78,903 ± 3572 Brn3a+ RGCs and 2,358 ± 144 melanopsin+ RGCs (n=10).
  • Retinal thinning (inner layers) was confirmed by SD-OCT at both 3 and 15 months, consistent with conventional RGC loss despite ipRGC survival.
Categories

Categories

Eye Health & Vision: Examines differential survival of melanopsin-containing RGCs versus conventional RGCs under excitotoxic retinal damage conditions.
The Science of Light: Provides evidence on the resilience of ipRGCs (melanopsin+ RGCs), the photoreceptors critical for non-visual light responses including circadian entrainment and the pupillary light reflex.
Authors

Author(s)

B Vidal-Villegas, J Di Pierdomenico
Publication Date

Publication Year

2019
Citations

Number of Citations

20
View more publications